News
Sugemalimab Monotherapy for Patients With Relapsed or Refractory Extranodal Natural Killer/T-Cell Lymphoma (GEMSTONE-201): Results From a Single-Arm, Multicenter, Phase II Study While overall survival ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback